AccScience Publishing / CP / Volume 1 / Issue 1 / DOI: 10.18063/cp.v1i1.221
Cite this article
33
Download
956
Views
Journal Browser
Volume | Year
Issue
Search
News and Announcements
View All
RESEARCH ARTICLE

LncRNA and Gene expression profiling of human bladder cancer

Zhao Yang1* Haifeng Wang2* Suhang Bai1 Zongyi Shen1 Zhong Bo1 Qiuyun Yan1 Dongxiao Cheng1 Wei Zhang4 Jian Zhuang5 Lingzhi Wang1 Xinlu Yu1 Fuhan Zhang1 Ruonan Gao1 Yuhan Yan6 Changyuan Yu1# Chong Li3#
Show Less
1 Department of Biomedical Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China
2 Department of Urology, Second Affiliated Hospital of Kunming Medical University, Kunming 650 101, China
3 Core Facility for Protein Research, Institute of Biophysics, Chinese Academy of Sciences, Beijing 10010, China
4 Department of Urology, Affiliated Hospital of Hebei University, Baoding 071 030, China
5 Institute of Plastic Machinery and Engineering, College of Mechanical and Electrical Engineering, Beijing University of Chemical Technology, Beijing 100029, China
6 Department of Management Science and Engineering, School of Business, Renmin University of China, Beijing 100872, China
CP 2019, 1(1), 43–49; https://doi.org/10.18063/cp.v1i1.221
Received: 7 March 2019 | Accepted: 14 March 2019 | Published online: 19 March 2019
© 2019 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )
Abstract

Bladder cancer (BC) is the most common urologic neoplasms with a high rate of recurrence. The formation of BC is a complicated process, resulting from smoke, drugs, or bladder inflammation. However, the underlying mechanisms of BC tumorigenesis remained unclear. In this study, we performed microarray analysis of three paired paratumor (PT) and tumor tissues from BC patients. In comparison with PT, BC tissues displayed 1136 upregulated and 1199 downregulated lncRNAs, and 1347 upregulated and 953 downregulated mRNAs. In addition, the upregulated mRNAs were focused in SNARE interactions, amino sugar and nucleotide sugar metabolism, and antigen processing pathways. The common downregulated genes were mainly focused in amino acid metabolism and drug metabolism signaling. More importantly, cytokinerelated genes were highly expressed in BC, which suggest that the dysregulation of immunoregulatory process and amino acid metabolism played a crucial role in the oncogenesis of BC.

Keywords
amino acid metabolism
bladder cancer
cytokine signaling pathway
lncRNA
References

Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68, 394-424 (2018).

Chen, W. et al. Cancer statistics in China, 2015. CA Cancer J Clin 66, 115-132 (2016).

Marcos-Gragera, R. et al. Urinary tract cancer survival in Europe 1999–2007: Results of the population-based study EUROCARE-5. European Journal of Cancer 51, 2217-2230 (2015).

Morales, A., Eidinger, D. & Bruce, A. W. Intracavitary bacillus calmette-guerin in the treatment of superficial bladder tumors *. Journal of Urology 167, 891-894 (1976).

Maase, H., Von Der et al. Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study. Journal of Clinical Oncology Official Journal of the American Society of Clinical Oncology 18, 3068 (2000).

Janković, S. & Radosavljević, V. Risk factors for bladder cancer. Tumori 93, 4-12 (2007).

Akbani, R. et al. Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer. Cell 171, págs. 540-556 (2017).

Choudhury, N. J. et al. Low T-cell Receptor Diversity, High Somatic Mutation Burden, and High Neoantigen Load as Predictors of Clinical Outcome in Muscle-invasive Bladder Cancer. Eur Urol Focus 2, 445-452 (2016).

Huang da, W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4, 44-57 (2009).

Smith, S. G. & Zaharoff, D. A. Future directions in bladder cancer immunotherapy: towards adaptive immunity. Immunotherapy 8, 351-365 (2016).

Gupta, R. A. et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464, 1071-1076 (2010).

Mercer, T. R., Dinger, M. E. & Mattick, J. S. Long non-coding RNAs: insights into functions. Nature Reviews Genetics 10, 155-159 (2009).

Anastasiadou, E., Jacob, L. S. & Slack, F. J. Non-coding RNA networks in cancer. Nat Rev Cancer 18, 5-18 (2018).

Gupta, R. A. et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464, 1071-1076 (2010).

Yang, F., Zhang, H., Mei, Y. & Wu, M. Reciprocal regulation of HIF-1alpha and lincRNA-p21 modulates the Warburg effect. Mol Cell 53, 88-100 (2014).

Share
Back to top
Cancer Plus, Electronic ISSN: 2661-3840 Print ISSN: 2661-3832, Published by AccScience Publishing